MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

St. Jude Unveils New Identity for its Neuromodulation Division

St. Jude Medical today announced that its neuromodulation division, formerly Advanced Neuromodulation Systems, has adopted the St. Jude Medical name. The St. Jude Medical Neuromodulation Division unveiled its new brand identity and showcased its flagship products at the 12th annual North American Neuromodulation Society (NANS) meeting, which began today in Las Vegas. St. Jude Medical acquired Advanced Neuromodulation Systems in 2005 and continued to develop, manufacture, and market implantable neuromodulation products under that name.

A new corporate brand identity features the theme, âEURoeMore Control. Less Risk.âEUR The message reflects St. Jude MedicalâEUR(TM)s dedication to advancing the practice of medicine by focusing on reducing risk wherever possible and contributing to successful outcomes for every patient. The company is developing new technologies to address a growing list of neurological disorders. Clinical studies are currently under way for ParkinsonâEUR(TM)s disease, essential tremor, migraine headaches and major depressive disorder among others. St. Jude Medical is showcasing the worldâEUR(TM)s smallest neurostimulator for chronic pain, the Eon Mini, which was launched in September 2008. It is also showing an expanded portfolio of products including EonC, St. Jude MedicalâEUR(TM)s first extended life nonrechargeable neurostimulator, and Cinch anchor, an accessory designed to secure neurostimulation leads to mitigate lead migration. The company is also presenting 15 poster and oral presentations representing research in areas such as deep brain stimulation for depression, peripheral field nerve stimulation for chronic pain, and spinal cord stimulation for chronic pain of the back, arms, and legs. These presentations reflect on the ongoing collaboration with physicians to develop new therapies for patients who have exhausted most other therapeutic options.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish